IntroductionRecent evidence suggests that for certain clinical conditions, placebos can improve clinical outcomes even without deception. These so-called open-label placebos (OLPs) bear the advantage of a significant lower risk of adverse events and ...
Cosima Locher+5 more
doaj +2 more sources
Reducing Emotional Distress with Open-Label Placebos: Assessing the Role of Motor Engagement in Pill Consumption [PDF]
It has been posited that ingesting a pill constitutes a pivotal action that facilitates the effects of open-label placebos (OLPs: placebos honestly prescribed).
Anne Schienle, Wolfgang Kogler
doaj +2 more sources
Open-label placebo clinical trials: is it the rationale, the interaction or the pill?
National surveys of primary care physicians demonstrate that placebo use is prevalent. Against their widespread use, until recently, it was assumed among researchers that placebos must be deceptively prescribed for beneficial effects to be elicited ...
C. Blease+2 more
semanticscholar +5 more sources
The role of patient beliefs in open-label placebo effects.
OBJECTIVE Recent research on open-label placebos, or placebos administered without deception or concealment, suggests that they can be effective in a variety of conditions.
Kari A Leibowitz+3 more
semanticscholar +5 more sources
More than consent for ethical open-label placebo research
Recent studies have explored the effectiveness of open-label placebos (OLPs) for a variety of conditions, including chronic pain, cancer-related fatigue and irritable bowel syndrome. OLPs are thought to sidestep traditional ethical worries about placebos
Laura Specker Sullivan
semanticscholar +4 more sources
Noble Humbug? Hard and soft laws on clinical placebo use [PDF]
Despite the widespread historical and contemporary use of placebos in medicine, legal regulations addressing their administration remain limited in many countries.
Mélina Richard+9 more
doaj +2 more sources
Conditioned open-label placebos to facilitate opioid reduction in patients with chronic non-cancer pain: study protocol of a randomised controlled trial [PDF]
Introduction Chronic non-cancer pain presents a global health problem, with a significant increase in opioid prescriptions over recent decades. However, opioid therapy poses risks of adverse events, overdose and non-medical use.
Cosima Locher+13 more
doaj +2 more sources
Introduction More than 2 million individuals in the USA have an opioid use disorder (OUD). Methadone maintenance treatment is the gold standard of medication-based treatment for OUD, but high-dose methadone is associated with cardiotoxicity and ...
Annabelle M Belcher+15 more
doaj +2 more sources
Effects of open-label placebos across populations and outcomes: an updated systematic review and meta-analysis of randomized controlled trials [PDF]
This work synthesizes and updates findings from previous systematic-reviews and meta-analyses on open-label placebos (OLPs). For the first time, it directly tests whether OLPs differ in effects between clinical and non-clinical samples, and between self ...
Johannes C. Fendel+4 more
doaj +2 more sources
A systematic qualitative review of ethical issues in open label placebo in published research [PDF]
Open-label placebos (OLPs), which are transparently administered inert treatments, have gained increasing attention in the research community. They have the potential to harness placebo effects without deceiving the patient. The purpose of this study was
Mélina Richard+3 more
doaj +2 more sources